Cambrian BioPharma Inc
SEC CIK 1797409 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | 10%, See Remarks | 130.1K | $2.16M | $787.8K | 34 | 2021-02-18 | 2026-06-01 |
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-01 17:21 | 2026-06-01 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | S - Sale | $20.02 | -25.0K | 130.1K | -16% | -$500.5K |
| DM | 2025-12-10 | 2025-12-09 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | S - Sale+OE | $8.25 | -6,612 | 155.6K | -4% | -$54.6K |
| D | 2025-12-10 | 2025-12-09 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | M - OptEx | $6.40 | +395 | 156.0K | +0.3% | +$2,528 |
| M | 2025-12-08 | 2025-12-04+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | S - Sale | $10.93 | -21.3K | 161.4K | -12% | -$232.7K |
| 2023-08-02 | 2023-07-31 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10%, See Remarks | D - Sale to Iss | $1.26 | -1.59M | 3.65M | -30% | -$2.00M | |
| D | 2023-07-12 | 2023-07-10 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | A - Grant | $0.00 | +4,466 | 5.24M | +0.1% | $0 |
| DA | 2023-03-07 | 2022-06-10 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | A - Grant | $0.00 | +4,466 | 5.24M | +0.1% | $0 |
| D | 2022-06-14 | 2022-06-10 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | A - Grant | $0.00 | +4,466 | 5.24M | +0.1% | $0 |
| A | 2022-06-10 | 2022-03-02 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $3.20 | +1,203 | 5.23M | +0.0% | +$3,850 |
| A | 2022-04-21 | 2021-03-23 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $14.34 | +9,500 | 4.80M | +0.2% | +$136.2K |
| A | 2022-04-21 | 2021-02-18 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $19.75 | +752 | 4.69M | +0.0% | +$14.9K |
| 2022-03-02 | 2022-03-02 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $3.20 | +1,203 | 5.23M | +0.0% | +$3,850 | |
| M | 2022-03-01 | 2022-02-28+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $3.60 | +2,500 | 5.23M | +0.0% | +$9,000 |
| 2022-02-28 | 2022-02-25 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $3.65 | +2,500 | 5.23M | +0.0% | +$9,125 | |
| M | 2022-02-24 | 2022-02-23+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $3.65 | +17.5K | 5.21M | +0.3% | +$64.0K |
| M | 2022-02-22 | 2022-02-17+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.02 | +19.9K | 5.21M | +0.4% | +$80.2K |
| M | 2022-02-16 | 2022-02-14+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.19 | +12.6K | 5.19M | +0.2% | +$52.6K |
| M | 2022-02-14 | 2022-02-10+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.45 | +17.5K | 5.16M | +0.3% | +$77.9K |
| M | 2022-02-08 | 2022-02-03+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.53 | +30.0K | 5.16M | +0.6% | +$135.8K |
| M | 2022-01-31 | 2022-01-27+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.26 | +15.0K | 5.13M | +0.3% | +$63.8K |
| M | 2022-01-27 | 2022-01-25+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.72 | +50.0K | 5.11M | +1.0% | +$235.8K |
| M | 2022-01-25 | 2022-01-21+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.82 | +47.4K | 5.04M | +0.9% | +$228.5K |
| M | 2022-01-21 | 2022-01-19+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.10 | +30.2K | 5.02M | +0.6% | +$154.3K |
| 2022-01-20 | 2022-01-18 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.08 | +10.0K | 4.99M | +0.2% | +$50.8K | |
| M | 2022-01-18 | 2022-01-13+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.10 | +26.2K | 4.97M | +0.5% | +$133.4K |
| M | 2022-01-13 | 2022-01-11+ | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.20 | +20.0K | 4.95M | +0.4% | +$104.2K |
| 2022-01-11 | 2022-01-10 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.28 | +10.0K | 4.93M | +0.2% | +$52.8K | |
| 2022-01-03 | 2021-12-30 | FTH | Faeth Therapeutics, Inc. | 10% | P - Purchase | $4.85 | +1,127 | 4.92M | +0.0% | +$5,466 | ||
| 2021-12-30 | 2021-12-29 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $4.98 | +69.0K | 4.92M | +1% | +$343.6K | |
| 2021-12-29 | 2021-12-28 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.28 | +11.3K | 4.85M | +0.2% | +$59.6K | |
| 2021-12-27 | 2021-12-27 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.30 | +3,712 | 4.84M | +0.1% | +$19.7K | |
| 2021-12-23 | 2021-12-23 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.27 | +11.0K | 4.83M | +0.2% | +$58.0K | |
| 2021-12-21 | 2021-12-17 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.29 | +117 | 4.82M | +0.0% | +$618.93 | |
| 2021-12-20 | 2021-12-16 | FTH | Faeth Therapeutics, Inc. | Cambrian BioPharma Inc | 10% | P - Purchase | $5.25 | +10.9K | 4.82M | +0.2% | +$57.4K |
Purchase Sale Sale after option exercise All abbreviations